Select a State

Global health R&D delivers for Oklahoma

US government investment in global health R&D has delivered

$9.8 million
to Oklahoma research institutions
100+ new jobs
for Oklahoma

Neglected diseases in Oklahoma

Chikungunya cases
18
Dengue cases
17
HIV diagnoses
2,718
Malaria cases
74
Tuberculosis cases
744
West Nile cases
434
Zika cases
30

Oklahoma's top USG-funded global health R&D institutions

University of Oklahoma
$6.0 million
Oklahoma State University
$3.8 million

Oklahoma industry in global health R&D

Accele Biopharma
Location(s):
Oklahoma City
GSK
Location(s):
Oklahoma City
Immy
Location(s):
Norman
Northbound Therapeutics
Location(s):
Oklahoma City
Pamlico BioPharma
Location(s):
Oklahoma City

Oklahoma's top areas of global health R&D by USG funding

8.6%
Malaria
24.2%
Diarrheal diseases
3.0%
Salmonella infections
53.4%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
10.8%
Other
Non-allocable
Tuberculosis

Global health R&D at work in Oklahoma

Researchers at the University of Oklahoma have discovered a new approach to block the malaria parasite from infecting mosquitoes. This important discovery could lead to a new vaccine. The researchers found that an antibody used against a key mosquito protein stopped the malaria parasite from invading mosquitoes. Vaccination with this protein could dramatically reduce the number of malaria cases around the world by preventing mosquitoes from transmitting the disease. Each year, more than 200 million people are infected with malaria and half a million die from the disease, most of whom are young children. Approximately half of the world’s population is at risk. Scientists are racing to create a malaria vaccine and new drug treatments before resistance to current antimalarials spreads.

Footnotes